Effects of an H3R Antagonist on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid

Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders primarily characterized by impaired social interaction and communication, and by restricted repetitive behaviors and interests. Ligands of histamine receptor 3 (H3R) are considered potential therapeutic agents for the treatment of different brain disorders and cognitive impairments. Considering this, the aim of the present study is to evaluate the actions of ciproxifan (CPX), an H3R antagonist, on the animal model of autism induced by prenatal exposure to valproic acid (VPA). Swiss mice were prenatally exposed to VPA on embryonic day 11 and assessed for social behavior, nociceptive threshold and repetitive behavior at 50 days of life. The treatment with CPX (3 mg/kg) or saline was administered 30 minutes before each behavioral test. The VPA group presented lower sociability index compared to VPA animals that were treated with CPX. Compared to the Control group, VPA animals presented a significantly higher nociceptive threshold, and treatment with CPX was not able to modify this parameter. In the marble burying test, the number of marbles buried by VPA animals was consistent with markedly repetitive behavior. VPA animals that received CPX buried a reduced amount of marbles. In summary, we report that an acute dose of CPX is able to attenuate sociability deficits and stereotypies present in the VPA model of autism. Our findings have the potential to help the investigations of both the molecular underpinnings of ASD and of possible treatments to ameliorate the ASD symptomatology, although more research is still necessary to corroborate and expand this initial data.

• Publication year

  2015

• Venue

  PLoS ONE

• Publication date

  2015-01-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pone.0116363PMID 25560049PMCID 4283962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prenatal Exposure to Valproate in Animals and Autism

  2014cited by this paper
• The other side of the histamine H3 receptor.

  2014cited by this paper
• Late onset deficits in synaptic plasticity in the valproic acid rat model of autism

  2014cited by this paper
• Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

  2013cited by this paper
• The role of histamine receptors in the consolidation of object recognition memory.

  2013cited by this paper
• The Neglected Role of Histamine in Alzheimer’s Disease

  2013cited by this paper
• Single dose of H3 receptor antagonist - ciproxifan - abolishes negative effects of chronic stress on cognitive processes in rats

  2013cited by this paper
• Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus.

  2013cited by this paper
• Knockout of NMDA Receptors in Parvalbumin Interneurons Recreates Autism‐Like Phenotypes

  2013cited by this paper
• The genetic basis of Gilles de la Tourette Syndrome.

  2013cited by this paper
• The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

  2013cited by this paper
• The genetic landscapes of autism spectrum disorders.

  2013cited by this paper
• Histamine regulation of innate and adaptive immunity.

  2012cited by this paper
• SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents.

  2012cited by this paper
• Overdose of the histamine H3 inverse agonist pitolisant increases thermal pain thresholds

  2012cited by this paper
• Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study.

  2012cited by this paper
• Ciproxifan, a histamine H3‐receptor antagonist / inverse agonist, modulates methamphetamine‐induced sensitization in mice

  2011cited by this paper
• Histamine receptors in the CNS as targets for therapeutic intervention.

  2011cited by this paper
• Histamine Pharmacology and New CNS Drug Targets

  2011cited by this paper
• Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice.

  2011cited by this paper
• Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease

  2011cited by this paper
• The histamine H3 receptor: from discovery to clinical trials with pitolisant

  2011cited by this paper
• Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid.

  2010cited by this paper
• Better working memory for non-social targets in infant siblings of children with Autism Spectrum Disorder.

  2010cited by this paper
• Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists

  2010cited by this paper
• Genetic overlap between autism, schizophrenia and bipolar disorder

  2009cited by this paper
• Histamine in the nervous system.

  2008cited by this paper
• The ‘Fractionable Autism Triad’: A Review of Evidence from Behavioural, Genetic, Cognitive and Neural Research

  2008cited by this paper
• Spatial Working Memory Deficits in Autism

  2007cited by this paper
• Histaminergic Involvement in Neuropathic Pain Produced by Partial Ligation of the Sciatic Nerve in Rats

  2006cited by this paper
• Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

  2005cited by this paper
• Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism

  2005cited by this paper
• Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists.

  2002cited by this paper
• Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design

  2001cited by this paper
• Autistic Disorder and Schizophrenia: Diagnostic Overlaps

  2001cited by this paper
• Niaprazine in the Treatment of Autistic Disorder

  1999cited by this paper
• Oral famotidine: a potential treatment for children with autism.

  1997cited by this paper
• Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats

  1997cited by this paper
• Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei

  1996cited by this paper
• Role of histamine in rodent antinociception

  1994cited by this paper
• Modulation of morphine-induced antinociception in mice by histamine H3-receptor ligands

  1994cited by this paper
• The differential effects of histamine receptor antagonists on morphine- and U-50,488H-induced antinociception in the mouse.

  1994cited by this paper
• Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs

  1994cited by this paper
• Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs.

  1994cited by this paper
• Effect of famotidine on deficit symptoms of schizophrenia.

  1990cited by this paper
• Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.

  1981cited by this paper
• Opiate-like and abstinence-like effects of intracerebral histamine administration in rats

  1978cited by this paper

• Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment

  2026cites this paper
• Perineuronal nets in the insular cortex shape salience-related behaviour in diabetes.

  2026cites this paper
• Pharmacological Evaluation of Betulinic Acid in Sodium Valproate-Induced Autism Spectrum Disorder in Rat Pups

  2026cites this paper
• The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety‐ and Depressive‐Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors

  2026cites this paper
• Nesfatin1 attenuates autism-like behavior via antioxidant, anti-inflammatory activities in a prenatal valproic acid-induced rat model of autism.

  2025cites this paper
• Models of Bosch-Boonstra-Schaaf optic atrophy syndrome reveal genotype-phenotype correlations in brain structure and behavior

  2025cites this paper
• Context blindness in the BTBR T+ tf mouse model of autism: Impaired contextual control of discrimination reversal learning.

  2025cites this paper
• ⁠⁠Functional Foods Alleviate Behavioral Alterations and Improve GABAergic System Regulating TLR‐4/NF‐κB Axis in Valproic‐Induced Autism

  2025cites this paper
• Prenatal modulation of NADPH-oxidase reverses the deranged GABA switch and rescues behavioral deficits in valproate ASD rat model

  2025cites this paper
• Brain-Resident Immune Cells in Neurodevelopmental Disorders.

  2025cites this paper
• Plumbagin Alleviates Social Behavior Deficits in a Valproic Acid Model of Autism by Reducing Glial Activation and Oxidative Stress in the Cerebellum

  2025cites this paper
• Sex-Specific Behavioral Features of the Prenatal Valproic Acid Rat Model of Autism Spectrum Disorder

  2025cites this paper
• Zeolite Imidazole Framework‐8 Exacerbates Astrocyte Activation and Oxidative Stress in the Brain of Rats

  2025cites this paper
• Mitigating effects of H3 receptor antagonism on cerebellar autophagic pathways and behavioral phenotypes in BTBR T+ tf/J mouse model of autism spectrum disorder.

  2025cites this paper
• Behavioral and Antioxidant Profiling in a Rat Autism Model: Protective Effects of Red Grape Extract

  2025cites this paper
• Optimizing prenatal valproic acid exposure in zebra finches to model autism-related phenotypes.

  2025cites this paper
• Possible Mechanism of Repetitive Stereotypic Movement Patterns in Autism Spectrum Disorders (A Role of Neuromodulators)

  2025cites this paper
• Acetyl-l-carnitine alleviates valproate-induced autism-like behaviors through attenuation of hippocampal mitochondrial dysregulation.

  2024cites this paper
• Histamine H3 receptor antagonists/inverse agonists: a patent review (October 2017 – December 2023) documenting progress

  2024cites this paper
• Developmental Trajectory of Autistic-Like Behaviors in a Prenatal Valproic Acid Rat Model of Autism.

  2024cites this paper
• A comparison of cognitive decline in aged mice and mice treated with aftin-4

  2024cites this paper
• Transient CSF1R inhibition ameliorates behavioral deficits in Cntnap2 knockout and valproic acid-exposed mouse models of autism

  2024cites this paper
• Cardiovascular developmental hazards of valproic acid in zebrafish.

  2024cites this paper
• Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice

  2024cites this paper
• Pharmacological intervention of behavioural traits and brain histopathology of prenatal valproic acid-induced mouse model of autism

  2024cites this paper
• Unveiling Niaprazine’s Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent

  2024cites this paper
• Neuroprotective effect of PPAR gamma agonist in rat model of autism spectrum disorder: Role of Wnt/β-catenin pathway.

  2024cites this paper
• Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders

  2024cites this paper
• Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder

  2024cites this paper
• Serine racemase deletion alters adolescent social behavior and whole-brain cFos activation

  2024cites this paper
• 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases

  2024cites this paper
• Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.

  2024cites this paper
• Testing the extreme male hypothesis in the valproate mouse model; sex-specific effects on plasma testosterone levels and tyrosine hydroxylase expression in the anteroventral periventricular nucleus, but not on parental behavior

  2023cites this paper
• A de novo variant in RERE causes autistic behavior by disrupting related genes and signaling pathway

  2023cites this paper
• Zebrafish embryonically exposed to valproic acid present impaired retinal development and sleep behavior

  2023cites this paper
• The Roles of Histamine Receptor 1 (hrh1) in Neurotransmitter System Regulation, Behavior, and Neurogenesis in Zebrafish

  2023cites this paper
• Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist

  2023cites this paper
• Sleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics

  2023cites this paper
• Critical Evaluation of Valproic Acid-Induced Rodent Models of Autism: Current and Future Perspectives

  2022cites this paper
• Histamine H3 receptor antagonists - Roles in neurological and endocrine diseases and diabetes mellitus.

  2022cites this paper
• Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice

  2022cites this paper
• Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism

  2022cites this paper
• In-silico discovery of dual active molecule to restore synaptic wiring against autism spectrum disorder via HDAC2 and H3R inhibition

  2022cites this paper
• Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism

  2022cites this paper
• A Need for Consistency in Behavioral Phenotyping for ASD: Analysis of the Valproic Acid Model

  2021cites this paper
• Selection of Young Animal Models of Autism over Adult: Benefits and Limitations

  2021cites this paper
• Adolescent alcohol binge-drinking compromises behaviors during adulthood without triggering neuroinflammation

  2021cites this paper
• [Nociception pain and autism].

  2021cites this paper
• The Multi-Targeting Ligand ST-2223 with Histamine H3 Receptor and Dopamine D2/D3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice

  2021cites this paper
• Exposure to sevoflurane results in changes of transcription factor occupancy in sperm and inheritance of autism

  2021cites this paper
• The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions.

  2021cites this paper
• Functional Assessment of Peripheral Cholinergic Neurotransmission in Rats with Fetal Valproate Syndrome

  2021cites this paper
• Dynamic regulation of oxytocin neuronal circuits in the sequential processes of prosocial behavior in rodent models

  2021cites this paper
• Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model?

  2021cites this paper
• The tuberomamillary nucleus in neuropsychiatric disorders.

  2021cites this paper
• Histamine, Neuroinflammation and Neurodevelopment: A Review

  2021cites this paper
• Overexpression of mGluR7 in the Prefrontal Cortex Attenuates Autistic Behaviors in Mice

  2021cites this paper
• Effects of Prenatal and Early Postnatal Administration of Valproate on Behavior and Cyhtological Characteristics in Wistar Rats

  2021cites this paper
• The role of T-cells in neurobehavioural development: insights from the immunodeficient nude mice.

  2021cites this paper
• Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.

  2021influential citation
• Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish

  2021influential citation
• Functional Assessment of Peripheral Cholinergic Neurotransmission in Rats with Fetal Valproate Syndrome

  2021cites this paper
• Maternal Immune Activation and Neuropsychiatric Disorders: The Intricate Puzzle of Autism Spectrum Disorder

  2020cites this paper
• Perinatal Inflammation and Adult Psychopathology: From Preclinical Models to Humans

  2020cites this paper
• Medium and long-term effects of low doses of Chlorpyrifos during the postnatal, preweaning developmental stage on sociability, dominance, gut microbiota and plasma metabolites.

  2020cites this paper
• Simultaneous Blockade of Histamine H3 Receptors and Inhibition of Acetylcholine Esterase Alleviate Autistic-Like Behaviors in BTBR T+ tf/J Mouse Model of Autism

  2020cites this paper
• A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism

  2020cites this paper
• Adolescent Alcohol Binge-Drinking Insidiously Impairs Adult Behavior In Mice

  2020cites this paper
• Prenatal pregabalin is associated with sex‐dependent alterations in some behavioral parameters in valproic acid‐induced autism in rat offspring

  2020influential citation
• Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?

  2020influential citation
• Sex dependent alterations of resveratrol on social behaviors and nociceptive reactivity in VPA-induced autistic-like model in rats.

  2020cites this paper
• Models of Autism and Methods for Assessing Autistic-Like Behavior in Animals

  2020cites this paper
• The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice

  2020influential citation
• Consequences of VGluT3 deficiency on learning and memory in mice.

  2019cites this paper
• The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammation in sodium valproate induced autism in mice.

  2019cites this paper
• Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder.

  2019cites this paper
• Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function

  2019cites this paper
• Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

  2018cites this paper
• Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio)

  2018cites this paper
• Physiopathologie des déficits moteurs dans les troubles du spectre autistique : approche neuroanatomique dans deux modèles environnementaux

  2018cites this paper
• Histaminergic Modulation of Recognition Memory

  2018cites this paper
• Modeling the quantitative nature of neurodevelopmental disorders using Collaborative Cross mice

  2018cites this paper
• Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System

  2018cites this paper
• Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models

  2018cites this paper
• Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.

  2018cites this paper
• The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism

  2018influential citation
• Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid

  2018cites this paper
• Intracellular Pathogen Infections and Immune Response in Autism

  2018cites this paper
• Brain histamine modulates recognition memory: possible implications in major cognitive disorders

  2018influential citation
• Immune Alterations in CD8+ T Cells Are Associated with Neuronal C-C and C-X-C Chemokine Receptor Regulation Through Adenosine A2A Receptor Signaling in a BTBR T+ Itpr3tf/J Autistic Mouse Model

  2018cites this paper
• Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid.

  2018cites this paper
• Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder

  2018cites this paper
• Modelling fragile X syndrome in the laboratory setting: A behavioral perspective

  2018cites this paper
• Why is vitamin B6 effective in alleviating the symptoms of autism?

  2018cites this paper
• Resveratrol attenuates pro‐inflammatory cytokines and activation of JAK1‐STAT3 in BTBR T+ Itpr3tf/J autistic mice

  2018cites this paper
• Animal models for autism in 2017 and the consequential implications to drug discovery

  2017cites this paper
• Pediatric Motor Stereotypies: An Updated Review

  2017cites this paper
• Neuropharmacological Properties of the Histaminergic System in the Zebrafish

  2017cites this paper
• Déterminants Moteurs des Troubles du Spectre Autistiques (TSA)

  2017cites this paper
• Motor determinants of autism spectrum disorder (ASD)

  2017cites this paper